Inmed Pharmaceuticals Inc stock is traded at $13.21, with a volume of 32,864. It is up +50.97% in the last 24 hours and up +1,886% over the past month. InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Previous Close:
$8.75
Open:
$14.00
24h Volume:
32,864
Relative Volume:
0.16
Market Cap:
$7.26M
Revenue:
$3.25M
Net Income/Loss:
-$8.34M
P/E Ratio:
-
EPS:
-$2.58
Net Cash Flow:
-$7.71M
1W Performance:
+1,551%
1M Performance:
+1,886%
6M Performance:
+3,537%
1Y Performance:
+1,450%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.7425$15.50
52-Week Range:
$0.2875$15.50
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Name
Inmed Pharmaceuticals IncSector
HealthcarePhone
(604) 669-7207Address
1445-885 WEST GEORGIA ST., VANCOUVER, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS